With the introduction of coronavirus disease 2019 (COVID-19) vaccines, the Korea Disease Control and Prevention Agency (KDCA) commissioned the National Academy of Medicine of Korea to gather experts to independently assess post-vaccination adverse events. Accordingly, the COVID-19 Vaccine Safety Research Committee (CoVaSC) was launched in November 2021 to perform safety studies and establish evidence for policy guidance. The CoVaSC established 3 committees for epidemiology, clinical research, and communication. The CoVaSC mainly utilizes pseudonymized data linking KDCA’s COVID-19 vaccination data and the National Health Insurance Service’s claims data. The CoVaSC’s 5-step research process involves defining the target diseases and organizing ad-hoc committees, developing research protocols, performing analyses, assessing causal relationships, and announcing research findings and utilizing them to guide compensation policies. As of 2022, the CoVaSC completed this research process for 15 adverse events. The CoVaSC launched the COVID-19 Vaccine Safety Research Center in September 2022 and has been reorganized into 4 divisions to promote research including international collaborative studies, long-/short-term follow-up studies, and education programs. Through these enhancements, the CoVaSC will continue to swiftly provide scientific evidence for COVID-19 vaccine research and compensation and may serve as a model for preparing for future epidemics of new diseases.
Citations
Citations to this article as recorded by
To become a more stronger and safer country Jong-Koo Lee Osong Public Health and Research Perspectives.2023; 14(2): 67. CrossRef
A Possible Type IV Hypersensitivity Reaction to Older Antiepileptic Drugs During and
After Recovery from COVID-19 Infection Mohsen Khosravi Pharmacopsychiatry.2022; 55(01): 58. CrossRef
Points to consider for COVID-19 vaccine quality control and national lot release in Republic of Korea: focus on a viral vector platform Jung Hun Ju, Naery Lee, Sun-hee Kim, Seokkee Chang, Misook Yang, Jihyun Shin, Eunjo Lee, Sunhwa Sung, Jung-Hwan Kim, Jin Tae Hong, Ho Jung Oh Osong Public Health and Research Perspectives.2022; 13(1): 4. CrossRef
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection Chang Kyung Kang, Hyun Mu Shin, Pyoeng Gyun Choe, Jiyoung Park, Jisu Hong, Jung Seon Seo, Yung Hie Lee, Euijin Chang, Nam Joong Kim, Minji Kim, Yong-Woo Kim, Hang-Rae Kim, Chang-Han Lee, Jun-Young Seo, Wan Beom Park, Myoung-don Oh BMC Medicine.2022;[Epub] CrossRef
Impact of national Covid-19 vaccination Campaign, South Korea Seonju Yi, Young June Choe, Do Sang Lim, Hye Roen Lee, Jia Kim, Yoo-Yeon Kim, Ryu Kyung Kim, Eun Jung Jang, Sangwon Lee, Eunjoo Park, Seung-Jin Kim, Young-Joon Park Vaccine.2022; 40(26): 3670. CrossRef
Recent increase in the detection of human parainfluenza virus during the coronavirus disease-2019 pandemic in the Republic of Korea Heui Man Kim, Jee Eun Rhee, Nam-Joo Lee, Sang Hee Woo, Ae Kyung Park, Jaehee Lee, Cheon Kwon Yoo, Eun-Jin Kim Virology Journal.2022;[Epub] CrossRef